AzTrials
AzTrials

Varicose UlcerPhase 1NCT00727701

Study of Individualized Wound Prevention Instruction to Prevent Venous Ulcer Development

A Phase 1 study testing Aftercare summary in people with Varicose Ulcer, run by US Department of Veterans Affairs at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether individualized wound prevention instructions will lengthen the ulcer-free period in veterans with recently healed venous ulcers. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Varicose Ulcer
What is being tested?
Aftercare summary
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteUnited States
Study dates
Jul 2008to Jun 2009
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Confirmed venous ulcer (ICD-9: 454.0, 454.2, 459.11, 459.13, 459.31, 459.33);
  • Documented healing of all lower extremity ulcers;
  • Ankle-brachial index (ABI) > 0.8 to rule out arterial insufficiency

Who cannot join

  • Unwilling or unable to sign informed consent;
  • No plans to seek care at VA Puget Sound within 6 months;
  • Limbs with ulcers or threatened viability

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VA Puget Sound Health Care System, Seattle

    Seattle, Washington, 98101

Other trials in United States

About this study

Official title: Does Use of a Wound After-care Summary for Patients With a History of Venous Ulcers Lower Recurrence Rate?

The purpose of this study is to determine whether individualized wound prevention instructions will lengthen the ulcer-free period in veterans with recently healed venous ulcers.

Read the detailed description

Venous ulcer disease is the most common form of lower extremity ulcer, and treatment requires months to years of costly intervention. Preventing venous ulcers from recurring is ideal, however, healing time is variable, possibly due to inadequate patient/clinician communication and surveillance. An aftercare summary is a detailed set of self-care instructions designed to help patients understand and influence preventative factors under their control. They have successfully been used in patients with cardiac disease and are currently being tested to help prevent diabetic foot ulcers. We propose the use of an aftercare summary to help prevent ulcer recurrence in veterans with recently healed venous ulcers.

Conditions
Varicose Ulcer
Being tested
Aftercare summary
Keywords
varicose ulcer, veteran, recurrence, aftercare
Medical subject headings
Varicose Ulcer, Recurrence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aftercare summaryBehavioural

    A personalized, targeted set of self-care instructions for venous ulcer prevention, including a graphical depiction of patient adherence to self-care goals.

Study groups in NCT00727701
Study groupRoleWhat they receive
1ExperimentalWill receive usual wound prevention care, aftercare summaries, and regular surveillance.
Receives: Behavioral: Aftercare summary
2No interventionWill receive usual wound prevention and surveillance only.
3No interventionWill receive usual wound prevention only.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ulcer-free survival period

    Measured: Telephone call every 2 weeks, on-site visit quarterly (depends on study arm)

Secondary outcomes (3)
  1. Change in quality of life

    Measured: Telephone call every 2 weeks, on-site visit at 2.5 and 5 months.

  2. Change in satisfaction with care

    Measured: Telephone call every 2 weeks, on-site visit at 2.5 and 5 months.

  3. Adherence with self-management goals

    Measured: Telephone call every 2 weeks, on-site visit at 2.5 and 5 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2008 (estimated)
  2. Study startJul 2008
  3. Primary completionJun 2009
  4. Study completionJun 2009

Why it stopped: Study delayed for over a year by research shutdown at Seattle VA and other issues. Study designer moved to Ann Arbor in the interim, so the study was closed.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
72 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00727701
Sponsor's protocol ID
08-246
Status last verified
Jun 2015
First submitted
30 Jul 2008
Last updated
26 Jun 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Aftercare summary in people with Varicose Ulcer, run by US Department of Veterans Affairs at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 26 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was stopped early (reason given: Study delayed for over a year by research shutdown at Seattle VA and other issues. Study designer moved to Ann Arbor in the interim, so the study was closed.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ulcer-free survival period (time frame: Telephone call every 2 weeks, on-site visit quarterly (depends on study arm)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2015; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in